AI-powered EMR software, Health Plix, revolutionizes prescription writing by providing real-time molecule-to-molecule interaction information
Health Plix Technologies, a leading provider of AI-powered Electronic Medical Record (EMR) software in India, has unveiled a groundbreaking feature called ‘Drug to Drug Interaction’ (DDI). This intuitive feature integrated into the Health Plix EMR platform aims to assist doctors by providing instant recall of molecule-to-molecule interactions at the point of care, thereby streamlining the prescription writing process.
The DDI feature is now live on the HealthPlix platform, empowering doctors with prompt reminders about potential interactions while prescribing medications to their patients. Traditionally, doctors relied on external websites or platforms to access information on drug interactions, leading to increased time spent on prescription writing. With HealthPlix, doctors can access this critical information within their EMR, saving valuable time and enhancing the quality of patient care.
Health Plix revolutionizes patient care with new feature enhancing doctor efficiency
Chaitanya Raju, Chief of AI at HealthPlix Technologies, expressed the company’s vision to develop assistive technologies that improve patient health outcomes. The launch of the DDI feature marks a significant milestone in achieving this vision, as HealthPlix’s interactive cloud-based EMR platform provides doctors with essential medical information precisely when they need it. Raju commended the product innovation team for their contributions.
Subhadeep Mondal, Vice President – Products at HealthPlix Technologies, highlighted the company’s commitment to strengthening the health-tech ecosystem and optimizing healthcare delivery. By suggesting interactions between incompatible drugs, the DDI feature aims to assist doctors in making informed prescribing decisions. To ensure the accuracy of its claims, HealthPlix intends to collaborate with organizations specializing in drug-to-drug interactions and reference research publications.
Medical professionals using the HealthPlix platform have already expressed their appreciation for the new feature. Dr. Peyush Khera, a Consultant Cardiologist, commended the DDI feature for its usefulness in reminding doctors about potential interactions between prescribed molecules. He emphasized that the feature displays on the screen without cluttering the printed prescription. Dr. Khera expressed gratitude for the new feature and expressed anticipation for future advancements.
With a well-defined reference interactions library, Health Plix aims to assist doctors in identifying potentially unsafe combinations of medications. The company plans to expand its database by integrating with global third-party providers specializing in drug-to-drug interactions. By March 2023, Health Plix aims to grow its reference interaction library from 4 lakh to 10 lakh entries, ensuring comprehensive and accurate information for doctors.
Health Plix Technologies continues to prioritize the needs of doctors and strives to empower them with digital tools that drive efficiency in their practice. In addition to the DDI feature, Health Plix has previously launched several products, including the Doctor Insights Dashboard, Patient Summary Dashboard, and Mobile EMR.
